Review

Classification and Antitumor Activities of Postbiotics from the Biotic Family

Volume: 12 Number: 2 December 14, 2023
TR EN

Classification and Antitumor Activities of Postbiotics from the Biotic Family

Abstract

Cancer is the second leading cause of death worldwide, and although the prognosis for patients has improved, it is still poor in a significant proportion of cases. Complex and inconclusive approaches to anticancer treatment in the human body motivate the search for new ways to create an anticancer environment. Studies have shown that probiotics, prebiotics, synbiotics and postbiotics are effective in their use as adjunctive therapy in cancer treatment. Postbiotics, from the biotic family, are health-promoting microbial metabolites offered as a functional food or dietary supplement. They directly affect the body's signaling pathways or indirectly manipulate the metabolism and composition of the intestinal microflora. The administration of postbiotics is an effective complementary strategy to fight cancer. In this review, studies including the antitumoral effects of postbiotics and their role in metastatic cancers were examined and the main findings showing the usefulness of postbiotic sources in tumor cells were summarized. Postbiotics can be considered as adjunctive therapy in cancer treatment and may help reduce the side effects caused by treatment methods. In addition, more in vivo and in vitro studies are needed to evaluate the effects of postbiotics on cancer in detail.

Keywords

References

  1. Açar, Y., & Sökülmez Kaya, P. (2021). Postbiyotikler ve sağlık üzerine etkileri: Sistematik derleme. Literatür Eczacılık Bilimleri Dergisi, 10(2), 276 – 284. https://doi.org/10.5336/pharmsci.2021-82004
  2. Aguilar-Toalá, J. E., Garcia-Varela, R., Garcia, H. S., Mata-Haro, V., González-Córdova, A. F., Vallejo-Cordoba, B., & Hernández-Mendoza, A. (2018). Postbiotics: An evolving term within the functional foods field. Trends in Food Science & Technology, 75, 105-114. https://doi.org/10.1016/j.tifs.2018.03.009
  3. Amaretti, A., Di Nunzio, M., Pompei, A., Raimondi, S., Rossi, M., & Bordoni, A. (2013). Antioxidant properties of potentially probiotic bacteria: in vitro and in vivo activities. Applied Microbiology and Biotechnology, 97, 809-817. https://doi.org/10.1007/s00253-012-4241-7
  4. Ayyash, M., Abu-Jdayil, B., Itsaranuwat, P., Galiwango, E., Tamiello-Rosa, C., Abdullah, H., Esposito, G., Hunashal, Y., Obaid R.S., & Hamed, F. (2020). Characterization, bioactivities, and rheological properties of exopolysaccharide produced by novel probiotic Lactobacillus plantarum C70 isolated from camel milk. International Journal of Biological Macromolecules, 144, 938-946. https://doi.org/10.1016/j.ijbiomac.2019.09.171
  5. Chen, S. M., Hsu, L. J., Lee, H. L., Lin, C. P., Huang, S. W., Lai, C. J. L., Lin, C. W., Chen, W. T., Chen, Y. J., Lin, Y. C., Yang, C. C., & Jan, M. S. (2020). Lactobacillus attenuate the progression of pancreatic cancer promoted by porphyromonas gingivalis in k-rasg12d transgenic mice. Cancers, 12(12), 3522. https://doi.org/10.3390/cancers12123522
  6. Chen, Z. Y., Hsieh, Y. M., Huang, C. C., & Tsai, C. C. (2017). Inhibitory effects of probiotic Lactobacillus on the growth of human colonic carcinoma cell line HT-29. Molecules, 22(1), 107. https://doi.org/10.3390/molecules22010107
  7. Chuah, L. O., Foo, H. L., Loh, T. C., Mohammed Alitheen, N. B., Yeap, S. K., Abdul Mutalib, N. E., Abdul Rahim, R., & Yusoff, K. (2019). Postbiotic metabolites produced by Lactobacillus plantarum strains exert selective cytotoxicity effects on cancer cells. BMC Complementary and Alternative Medicine, 19(1), 1-12. https://doi.org/10.1186/s12906-019-2528-2
  8. Cousin, F. J., Jouan-Lanhouet, S., Dimanche-Boitrel, M. T., Corcos, L., & Jan, G. (2012). Milk fermented by Propionibacterium freudenreichii induces apoptosis of HGT-1 human gastric cancer cells. PloS One, 7(3), e31892. https://doi.org/10.1371/journal.pone.0031892

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Review

Early Pub Date

December 3, 2023

Publication Date

December 14, 2023

Submission Date

February 10, 2023

Acceptance Date

October 27, 2023

Published in Issue

Year 2023 Volume: 12 Number: 2

APA
Aşit, M., & Saka, M. (2023). Classification and Antitumor Activities of Postbiotics from the Biotic Family. Ankara Sağlık Bilimleri Dergisi, 12(2), 212-221. https://doi.org/10.46971/ausbid.1249911
AMA
1.Aşit M, Saka M. Classification and Antitumor Activities of Postbiotics from the Biotic Family. Ankara Sağlık Bilimleri Dergisi. 2023;12(2):212-221. doi:10.46971/ausbid.1249911
Chicago
Aşit, Mert, and Mendane Saka. 2023. “Classification and Antitumor Activities of Postbiotics from the Biotic Family”. Ankara Sağlık Bilimleri Dergisi 12 (2): 212-21. https://doi.org/10.46971/ausbid.1249911.
EndNote
Aşit M, Saka M (December 1, 2023) Classification and Antitumor Activities of Postbiotics from the Biotic Family. Ankara Sağlık Bilimleri Dergisi 12 2 212–221.
IEEE
[1]M. Aşit and M. Saka, “Classification and Antitumor Activities of Postbiotics from the Biotic Family”, Ankara Sağlık Bilimleri Dergisi, vol. 12, no. 2, pp. 212–221, Dec. 2023, doi: 10.46971/ausbid.1249911.
ISNAD
Aşit, Mert - Saka, Mendane. “Classification and Antitumor Activities of Postbiotics from the Biotic Family”. Ankara Sağlık Bilimleri Dergisi 12/2 (December 1, 2023): 212-221. https://doi.org/10.46971/ausbid.1249911.
JAMA
1.Aşit M, Saka M. Classification and Antitumor Activities of Postbiotics from the Biotic Family. Ankara Sağlık Bilimleri Dergisi. 2023;12:212–221.
MLA
Aşit, Mert, and Mendane Saka. “Classification and Antitumor Activities of Postbiotics from the Biotic Family”. Ankara Sağlık Bilimleri Dergisi, vol. 12, no. 2, Dec. 2023, pp. 212-21, doi:10.46971/ausbid.1249911.
Vancouver
1.Mert Aşit, Mendane Saka. Classification and Antitumor Activities of Postbiotics from the Biotic Family. Ankara Sağlık Bilimleri Dergisi. 2023 Dec. 1;12(2):212-21. doi:10.46971/ausbid.1249911

Cited By

2560px-CC_BY-NC-ND.svg.png

Studies published in our journal are published as open access under CC BY-NC-ND 4.0 license.

Click here to get help about article submission processes and "Copyright Notice Form".